Abstract:

Pancreatoduodenectomy is an exceptional procedure that requires an extensive dissection of the supra-mesocolic region extended to the first jejunal limb. Lymphadenectomy, required for cancer, increases the dissection surface. The extensive preparation of the area is traditionally conducted with bipolar or monopolar instruments, while clips, ligatures, and sutures are used for haemostasis. LigaSure™ vessel sealing (LSVS; Valleylab, Boulder, CO) is a technology that obtains vessel closure by using the body’s own collagen and elastin to create a permanent fusion zone. This is obtained by a combination of forceps pressure and radio frequency. This effect has been improved by the introduction of the ForceTriad™ (Valleylab, Boulder, CO) energy platform, controlled by TissueFect™ (Valleylab, Boulder, CO) sensing technology. With this device, the surgeon is able to fuse vessels up to 7 mm, lymphatics, tissue bundles, and pulmonary vasculature in a fast-seal cycle of almost 4 seconds. In our daily practice of open surgery we observe a rapid improvement of abdominal drainage output with a drastic reduction of protein loss. Its practical significance is, in our opinion, that we obtain a rapid recovery of normal serum protein levels with a low number of blood/plasma sac transfusions and a real improvement of anastomosis healing. Moreover, the efficacy and the speed of work of the device allow us to reduce the operating time significantly but safely. We performed a retrospective analysis of the data of 20 pancreatic resections conducted both with traditional dissection and with the LigaSure Impact device with ForceTriad platform in order to verify whether observed data were real. Our clinical results show that the use of the LigaSure Impact device with ForceTriad energy platform is really useful in open surgery to save operating time, number of postoperative days, and hemoderivate administration.

Authors:

Giuseppe Piccinni, MD, Associate Professor of Surgery, University of Bari , Bari, Italy, Alessandro Pasculli, Student, University of Bari, Bari, Italy, Erasmina D’Ambrosio, MD, Junior Officer, University of Bari, Bari, Italy, Angela Gurrado, MD, PhD, Assistant Surgeon, University of Bari, Bari, Italy, Germana Lissidini, MD, PhD, Consultant , European Institute of Oncology, Milano, Italy , Mario Testini, MD, Full Professor of Surgery , University of Bari, Bari, Italy

PMID: 24081851

For Direct IP Access please click this link